S. Sherman
About
In The Last Decade
S. Sherman
8 papers receiving 622 citations
Peers
Comparison fields: 5 of 50
- Molecular Biology 416
- Developmental Neuroscience 286
- Cellular and Molecular Neuroscience 224
- Genetics 104
- Ophthalmology 101
Countries citing papers authored by S. Sherman
This map shows the geographic impact of S. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sherman more than expected).
Fields of papers citing papers by S. Sherman
This network shows the impact of papers produced by S. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sherman. The network helps show where S. Sherman may publish in the future.
Co-authorship network of co-authors of S. Sherman
This figure shows the co-authorship network connecting the top 25 collaborators of S. Sherman. A scholar is included among the top collaborators of S. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Sherman. S. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Design Considerations and Performance of a Next-Generation Encapsulated Cell Technology Intraocular Implant Delivering VEGF-Antagonist | 2 |
| 2 | Continuous Intraocular Drug Delivery over 5 ½ Years: Ciliary Neurotrophic Factor (CNTF)Production by Encapsulated Cell Technology Implants Treating Patients with Retinitis Pigmentosa and Geographic Atrophy | 2 |
| 3 | Long-Term, Sustained Intraocular Delivery of a VEGF Antagonist Using Encapsulated Cell Technology Implant for the Treatment of Choroidal Neovascular Diseases | 1 |
| 4 | 139 | |
| 5 | Sustained Intraocular Delivery of a Receptor Antibody Using an Encapsulated Cell Technology Implant | 1 |
| 6 | 65 | |
| 7 | 403 | |
| 8 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.